Yu Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Convolutional Neural Network

Diffuse Large B Cell Lymphoma

Neoadjuvant Chemotherapy

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Shumei Liang, Qiuping Wang, Yang Wen, Yu Wang, Man Li, Qiongyao Wang, Juan Peng, Linlang Guo
Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation. Cancer science (2022)